These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37968421)

  • 1. Unveiling Potential Neurotoxic Mechansisms: Pb-Induced Activation of CDK5-p25 Signaling Axis in Alzheimer's Disease Development, Emphasizing CDK5 Inhibition and Formation of Toxic p25 Species.
    Lokesh M; Bandaru LJM; Rajanna A; Rao JS; Challa S
    Mol Neurobiol; 2024 May; 61(5):3090-3103. PubMed ID: 37968421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca
    Park J; Won J; Yang E; Seo J; Cho J; Seong JB; Yeo HG; Kim K; Kim YG; Kim M; Jeon CY; Lim KS; Lee DS; Lee Y
    Sci Rep; 2024 Jul; 14(1):15642. PubMed ID: 38977865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
    Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
    Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CDK5/P25 formation/inhibition in neurodegeneration.
    Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
    Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
    Song WJ; Son MY; Lee HW; Seo H; Kim JH; Chung SH
    PLoS One; 2015; 10(8):e0136950. PubMed ID: 26317805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
    Lopes JP; Oliveira CR; Agostinho P
    Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.
    Nikhil K; Viccaro K; Shah K
    Mol Neurobiol; 2019 Feb; 56(2):1366-1390. PubMed ID: 29948941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Lopes JP; Oliveira CR; Agostinho P
    Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.
    Chang KH; Multani PS; Sun KH; Vincent F; de Pablo Y; Ghosh S; Gupta R; Lee HP; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2011 May; 22(9):1452-62. PubMed ID: 21389115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
    Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
    Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
    Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
    Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
    Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
    J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.